Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 940 of 6351
-
New hope for rare kidney cancer: drug combo shows promise in late-stage trial
Disease control OngoingA clinical trial to compare the effectiveness of savolitinib plus durvalumab versus sunitinib in MET-driven (hepatocyte growth factor receptor), unresectable and locally advanced or metastatic PRCC (Papillary Renal Cell Carcinoma).
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New MRI scan could replace endoscopy for liver patients
Diagnosis CompletedThe goal of this research is to validate novel non-invasive Magnetic resonance imaging (MRI) biomarkers to detect Gastroesophageal varices (GEV) in patients with cirrhosis, including fractional flow change in the portal vein and elevated azygos flow. End-stage liver disease (cir…
Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
New drug may cut transfusions for MDS patients
Disease control OngoingA phase IIIb, open-label, single arm study to evaluate the efficacy and safety of luspatercept in patients with lower-risk MDS and ring-sideroblastic phenotype (MDS-RS)
Phase 3 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Heart drug acoramidis tested for Long-Term safety in rare amyloidosis
Disease control OngoingOpen-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Participants with Symptomatic Transthyretin Amyloid Cardiomyopathy Who Completed the Phase 3 ATTRibute-CM Trial (AG10-301)
Phase 3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for tough lung cancers: drug combo trial launches
Disease control OngoingThe goal of this clinical trial is to compare the safety and efficacy (how well the drug works) of acasunlimab (also known as GEN1046) when it is used alone (monotherapy) versus when it is combined with a cancer drug (pembrolizumab) for participants with relapsed/refractory (dise…
Phase 2 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New pill could help adults with low platelet disorder
Disease control CompletedThe purpose of this study is to determine whether HMPL-523 (sovleplenib) is safe and effective in the treatment of chronic Immune Thrombocytopenic Purpura (ITP).
Phase 3 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Precision radiation aims to stall prostate cancer spread
Disease control Recruiting nowThe study is an open label, multi-centre, randomized phase III study. The patients will be randomised in a 1:1 ratio to treatment consisting of * Arm A: MD-SBRT in addition to standard treatment * Arm B: Standard treatment Study population: Patients with hormone sensitive prost…
Sponsor: Karin Soderkvist • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for advanced breast cancer: experimental drug targets tumors after other treatments fail
Disease control OngoingA Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd
Phase 2 • Sponsor: Ambrx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
ER shock showdown: less fluid, early pressors vs. standard care
Disease control OngoingThis multicentre, randomised controlled trial will enrol 1000 patients presenting with septic shock to the emergency department (ED) of participating hospitals in Australia and New Zealand. Participants will receive haemodynamic resuscitation with either a restricted fluids and e…
Phase 3 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Lupus drug trial hopes to tame flares with targeted antibody
Disease control OngoingThis parallel-group, double-blind, placebo-controlled study will evaluate the efficacy and safety of obinutuzumab versus placebo in participants with active, autoantibody-positive systemic lupus erythematosus (SLE) who are treated with standard-of-care therapy.
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New mRNA vaccine aimed at preventing common but risky virus
Vaccine Stopped earlyThe main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety and reactogenicity of mRNA-1647 vaccine in all participants. The purpose of the Phase 3 extension substudy is to extend the observati…
Phase 3 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 08:04 UTC
-
New pill targets tough lung cancers in first human trial
Disease control Recruiting nowResearchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC), a group of lung cancers that have spread to nearby tissues or to other parts of the body. Epidermal growth factor receptor (EGFR) and human epidermal growth factor rece…
Phase 1/2 • Sponsor: Bayer • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New Two-Step transplant aims to cut deaths in blood cancer patients
Disease control Recruiting nowThis phase II clinical trial evaluates whether a modified modality of conditioning reduces treatment-related mortality (TRM) in patients who undergo a hematopoietic stem cell transplant (HSCT) for a hematological malignancy. HSCT is a curative therapy for many hematopoietic malig…
Phase 2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can a single injection calm infants waking from anesthesia?
Symptom relief Recruiting nowEmergence agitation is a clinical condition in which the child experiences a variety of behavioural disturbances including crying, thrashing, and disorientation during early awakening from anaesthesia. Emergence agitation is a common challenge in children with a reported incidenc…
Phase 2/3 • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New shot every 2 weeks could control tumor growth in gut cancers
Disease control OngoingThe purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET. Patients who experience progressive disease in the randomized part of the study may proceed to an open-label…
Phase 3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New antibody targets hidden plasma cells to treat kidney disease
Disease control CompletedMembranous nephropathy (MN) - the leading cause of nephrotic syndrome (NS) in adults - is an immune-mediated disease that results from the deposition of immunoglobulins and complement components onto the sub-epithelial layer of the glomerular capillary wall. The availability for …
Phase 2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
A new approach to keep injured workers on the job
Disease control CompletedThe Retaining Employment and Talent after Injury/Illness Network (RETAIN) demonstration is a collaborative effort between the U.S. Department of Labor (DOL) and the Social Security Administration (SSA) to improve employment outcomes for individuals who experience injuries or illn…
Sponsor: Mathematica Policy Research, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New DNA test could spare thousands from unnecessary thyroid surgery
Diagnosis Recruiting nowThis clinical trial evaluates deoxyribonucleic acid (DNA) methylation signatures in diagnosing and managing thyroid nodules. The purpose of this research is to develop a new test for thyroid cancer. This test will use needle biopsies (small collections of tissue with a needle) fr…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Cranberry extract: a berry for the belly and the brain?
Disease control CompletedThe objective of this double-blind, parallel, randomized placebo-controlled clinical trial is to evaluate the effects of consumption of polyphenol-rich cranberry extract standardized in PACs (36 mg PACs/capsule) on cardiometabolic and neurocognitive health in women and men presen…
Sponsor: Laval University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug targets Hard-to-Treat cancers in japanese patients
Disease control OngoingThe primary objectives of this study are as follows: Phase 1 (sequential dose-escalation): to evaluate the safety and tolerability of sacituzumab govitecan-hziy (SG) as a single agent and to determine the recommended Phase 2 dose (RP2D) of SG in Japanese participants with advanc…
Phase 1/2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC